InvestorLens

BRNS — BARINTHUS BIOTHERAPEUTICS PL

Public company

Sign in to save1 tracked investor reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About BARINTHUS BIOTHERAPEUTICS PL (BRNS)

BARINTHUS BIOTHERAPEUTICS PL (BRNS) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $83,171. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in BRNS

100
/100
Strong Institutional Accumulation
Added / Increased1
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track BRNS

7
/100
Undiscovered
1investor

Only 1 tracked investor report this position.

UndiscoveredCrowded
151015+

BRNS Ownership Composition

How BARINTHUS BIOTHERAPEUTICS PL is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
100% of tracked value
Institutions
1
tracked investors
Total Reported
$68.1K
combined 13F value
Sectors1
  • Other100.0%
Other(1)
100.0%

Tracked investors reporting BRNS

  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    119K
    Value
    $68.1K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold BRNS?
1 tracked institutional investor disclosed a position in BRNS (BARINTHUS BIOTHERAPEUTICS PL) in their most recent 13F filing.
Who is the largest institutional holder of BRNS?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in BRNS, valued at $83,171.
Did institutional ownership of BRNS increase or decrease?
Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited BRNS.
Where does this BRNS ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
BRNS (BARINTHUS BIOTHERAPEUTICS PL) — Institutional Holders — InvestorLens